Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
L.B. Foster | FSTR | Apr 29, 2024 | 24.21 | -1.02 |
L.S. Starrett | SCX | Apr 29, 2024 | 16.15 | +0.81 |
L3Harris Technologies | LHX | Apr 29, 2024 | 217.06 | +1.17 |
La Rosa Company | LRHC | Apr 29, 2024 | 1.74 | +2.35 |
La-Z-Boy | LZB | Apr 29, 2024 | 33.41 | +0.91 |
Labcorp | LH | Apr 29, 2024 | 204.17 | +2.91 |
Ladder Capital | LADR | Apr 29, 2024 | 10.91 | -0.82 |
Laird Superfood | LSF | Apr 29, 2024 | 2.01 | +1.52 |
Lake Shore Bancorp | LSBK | Apr 29, 2024 | 11.74 | +2.09 |
Lakeland Bancorp | LBAI | Apr 29, 2024 | 12.39 | -1.04 |
Lakeland Financial | LKFN | Apr 29, 2024 | 59.16 | -1.02 |
Lakeland Industries | LAKE | Apr 29, 2024 | 17.04 | -0.64 |
Lam Research | LRCX | Apr 29, 2024 | 928.81 | +0.37 |
Lamar Advertising A | LAMR | Apr 29, 2024 | 115.39 | +0.89 |
Lamb Weston | LW | Apr 29, 2024 | 84.67 | +0.98 |
LAMF Global Ventures I SPAC A | LGVC | Apr 29, 2024 | 7.35 | +8.09 |
Lancaster Colony | LANC | Apr 29, 2024 | 190.35 | +1.78 |
Landmark Bancorp | LARK | Apr 29, 2024 | 18.45 | -2.89 |
Landos Biopharma | LABP | Apr 29, 2024 | 22.48 | +0.76 |
Lands End | LE | Apr 29, 2024 | 13.93 | +7.07 |
Landsea Homes | LSEA | Apr 29, 2024 | 11.49 | +2.04 |
Landstar System | LSTR | Apr 29, 2024 | 177.23 | -0.02 |
Lantern Pharma | LTRN | Apr 29, 2024 | 4.93 | -10.36 |
Lantheus | LNTH | Apr 29, 2024 | 67.26 | +2.59 |
Lantronix | LTRX | Apr 29, 2024 | 3.46 | +5.81 |
Lanvin Group | LANV | Apr 29, 2024 | 1.51 | -4.73 |
Lanzatech Global | LNZA | Apr 29, 2024 | 2.22 | -0.45 |
Largecap Core Alphadex First Trust | FEX | Apr 29, 2024 | 96.07 | +0.55 |
Largecap Dividend Wisdomtree | DLN | Apr 29, 2024 | 70.13 | +0.47 |
Largecap ETF Vanguard | VV | Apr 29, 2024 | 233.91 | +0.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.